Chongqing Lummy Pharmaceutical (300006) — Financial Flexibility Index
Chongqing Lummy Pharmaceutical (300006) has a Financial Flexibility Index of 0.00x as of September 2025. Free cash flow of CN¥-4.17 Million (operating CF CN¥-14.90 Million minus capex CN¥10.73 Million) represents 0% of total liabilities (CN¥910.32 Million). Check Chongqing Lummy Pharmaceutical investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Chongqing Lummy Pharmaceutical Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Chongqing Lummy Pharmaceutical across 19 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Chongqing Lummy Pharmaceutical.
Annual Financial Flexibility Index for Chongqing Lummy Pharmaceutical (2006–2024)
Year-by-year free cash flow to debt coverage for Chongqing Lummy Pharmaceutical. Explore debt repayment capacity of Chongqing Lummy Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥260.54 Million | CN¥185.03 Million | CN¥972.47 Million | ▲ +46.2% |
| 2023 | 0.18x | CN¥140.85 Million | CN¥81.53 Million | CN¥768.71 Million | ▲ +27.2% |
| 2022 | 0.14x | CN¥125.32 Million | CN¥57.13 Million | CN¥870.02 Million | ▼ -29.9% |
| 2021 | 0.21x | CN¥146.94 Million | CN¥108.28 Million | CN¥714.65 Million | ▲ +46.9% |
| 2020 | 0.14x | CN¥268.12 Million | CN¥224.54 Million | CN¥1.92 Billion | ▼ -12.2% |
| 2019 | 0.16x | CN¥294.37 Million | CN¥231.30 Million | CN¥1.85 Billion | ▼ -35.8% |
| 2018 | 0.25x | CN¥351.82 Million | CN¥225.89 Million | CN¥1.42 Billion | ▲ +205.8% |
| 2017 | 0.08x | CN¥82.62 Million | CN¥61.39 Million | CN¥1.02 Billion | ▼ -67.5% |
| 2016 | 0.25x | CN¥202.63 Million | CN¥125.66 Million | CN¥809.85 Million | ▲ +1087.1% |
| 2015 | 0.02x | CN¥29.78 Million | CN¥-25.41 Million | CN¥1.41 Billion | ▼ -75.3% |
| 2014 | 0.09x | CN¥104.53 Million | CN¥-49.38 Million | CN¥1.23 Billion | ▼ -79.1% |
| 2013 | 0.41x | CN¥430.10 Million | CN¥74.70 Million | CN¥1.06 Billion | ▲ +48.5% |
| 2012 | 0.27x | CN¥195.51 Million | CN¥18.18 Million | CN¥713.21 Million | ▼ -21.5% |
| 2011 | 0.35x | CN¥146.95 Million | CN¥11.85 Million | CN¥420.81 Million | ▼ -17.6% |
| 2010 | 0.42x | CN¥136.63 Million | CN¥37.66 Million | CN¥322.42 Million | ▼ -2.9% |
| 2009 | 0.44x | CN¥56.09 Million | CN¥37.35 Million | CN¥128.55 Million | ▲ +34.7% |
| 2008 | 0.32x | CN¥42.35 Million | CN¥17.25 Million | CN¥130.77 Million | ▼ -13.8% |
| 2007 | 0.38x | CN¥40.12 Million | CN¥21.68 Million | CN¥106.78 Million | ▼ -2.1% |
| 2006 | 0.38x | CN¥23.30 Million | CN¥7.77 Million | CN¥60.72 Million | — |